Your browser doesn't support javascript.
loading
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies.
Danciu, Oana C; Holdhoff, Matthias; Peterson, Richard A; Fischer, James H; Liu, Li C; Wang, Heng; Venepalli, Neeta K; Chowdhery, Rozina; Nicholas, M Kelly; Russell, Meredith J; Fan, Timothy M; Hergenrother, Paul J; Tarasow, Theodore M; Dudek, Arkadiusz Z.
  • Danciu OC; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA. ocdanciu@uic.edu.
  • Holdhoff M; Clinical Trials Office, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA. ocdanciu@uic.edu.
  • Peterson RA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
  • Fischer JH; HealthPartners Institute, Regions Cancer Care Center, St. Paul, MN, USA.
  • Liu LC; Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.
  • Wang H; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA.
  • Venepalli NK; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, USA.
  • Chowdhery R; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Nicholas MK; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Russell MJ; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Fan TM; Clinical Trials Office, University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, IL, USA.
  • Hergenrother PJ; Vanquish Oncology, Inc., Champaign, IL, USA.
  • Tarasow TM; Department of Veterinary Clinical Medicine, University of Illinois, Urbana-Champaign, IL, USA.
  • Dudek AZ; Cancer Center at Illinois, Urbana-Champaign, IL, USA.
Br J Cancer ; 128(5): 783-792, 2023 03.
Article en En | MEDLINE | ID: mdl-36470974

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article